National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Ishii, H; Dumon, K R; Vecchione, A et al. (2001) Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells. Cancer Res 61:1578-84
Ishii, H; Vecchione, A; Murakumo, Y et al. (2001) FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis. Proc Natl Acad Sci U S A 98:10374-9
Vecchione, A; Zanesi, N; Trombetta, G et al. (2001) Cervical dysplasia, ploidy, and human papillomavirus status correlate with loss of Fhit expression. Clin Cancer Res 7:1306-12
Murakumo, Y; Roth, T; Ishii, H et al. (2000) A human REV7 homolog that interacts with the polymerase zeta catalytic subunit hREV3 and the spindle assembly checkpoint protein hMAD2. J Biol Chem 275:4391-7
Ishii, H; Baffa, R; Numata, S I et al. (1999) The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors. Proc Natl Acad Sci U S A 96:3928-33
Pekarsky, Y; Hallas, C; Isobe, M et al. (1999) Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes. Proc Natl Acad Sci U S A 96:2949-51
Zou, J P; Hirose, Y; Siddique, H et al. (1999) Structure and expression of variant BRCA2a lacking the transactivation domain. Oncol Rep 6:437-40
Numata, S; Claudio, P P; Dean, C et al. (1999) Bdp, a new member of a family of DNA-binding proteins, associates with the retinoblastoma gene product. Cancer Res 59:3741-7
Huebner, K; Garrison, P N; Barnes, L D et al. (1998) The role of the FHIT/FRA3B locus in cancer. Annu Rev Genet 32:7-31
Dhulipala, P D; Lee, L; Rao, V N et al. (1998) Fli-1b is generated by usage of differential splicing and alternative promoter. Oncogene 17:1149-57

Showing the most recent 10 out of 63 publications